Enable Injections said last week that it closed a $50 million Series B round, led by Sanofi (NYSE:SNY), to fund the development of its enFuse on-body drug-delivery system.
Previous investors, including the Cleveland Clinic and CincyTech, and private investors also participated in the round.
Get the full story at our sister site, Drug Delivery Business News.